For the selected time horizon ResMed has a risk adjusted performance of 0.01, jensen alpha of 0.0, total risk alpha of 0.0 and treynor ratio of 0.0Macroaxis provides advice on ResMed to complement and cross-verify current analyst consensus on ResMed. Our recommendation engine determines the corporation potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure ResMed is not overpriced, please check all ResMed fundamentals including its Revenue, Current Ratio, Market Capitalization, as well as the relationship between Cash and Equivalents and Earnings Per Share . Given that ResMed has Price to Earning of 52.68 times, we recommend you check out ResMed market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.
ResMed Thematic Classifications
ResMed Returns Distribution Density
ResMed Volatility Alert
|Better Than Average||Worse Than Average||Compare ResMed to competition|
ResMed Fundamental Vs Peers
ResMed Market Momentum
Additionally take a look at ResMed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.